Immune-stimulating microbiological components like lipopolysaccharide (LPS), lipoteichoic acid (LTA) and zymosan bound onto surfaces lead to severe problems when brought in contact with the organism via surgical instruments or implants. We have shown, in recent studies, that it is possible to detect different immune-stimulating components directly on the surface, via an indirect detection method, using human whole-blood and the monocyte reaction to measure the inflammatory mediator release (IL-1β) by ELISA. With regard to the inactivation of pyrogenic substances, we present a method based on the application of a low-pressure microwave plasma discharge working at low temperatures. We found a fast (10 s to a few minutes) removal rate of the immune-stimulating competence for LPS, LTA and zymosan. To mimic the bacterial cell-wall, LPS in combination with muramyl dipeptide was employed and the decreasing rate of the inflammatory signal did not differ from pure LPS.
INTRODUCTION
Surgical equipment, dental instruments and long-term implants are intended to penetrate the human body and, therefore, are coming in direct contact with the patient's first immune defense system. According to the existing guidelines, all these devices have to be sterilized and decontaminated, to prevent any kind of infection or inflammation. This is especially true for the cases of reused instruments, like endoscopes, bone-saw blades, neurosurgical or vascular tools, whose insufficient cleanliness has been reported to cause post-surgical problems. 1 The nature of the possible contamination is very diverse and ranges from the presence of living microorganisms (e.g. Gram-positive Staphylococcus aureus 2 ) to various biomolecules (e.g. prions, the transmission agents of Creutzfeld-Jacob disease [CJD]). 1 In addition, several compounds derived from bacteria or yeast are capable of inducing severe signs of inflammation, most often coupled with fever induction, when brought in contact with the mammalian blood stream, which consequently leads to clinical complications. 3 Typical examples of such fever-causing substances, generally called pyrogens, 4, 5 are bacterial endotoxins, like lipopolysaccharide (LPS, the main component of the Gram-negative bacterial cell-wall) as well as lipoteichoic acid (LTA) from Gram-positive bacteria, or zymosan, an insoluble preparation of yeast cells. Their presence in the human body invokes an immune response carried by monocytes and macrophages that can recognize body-foreign molecules via specialized receptors, 6 which is followed by the release of messenger substances, called cytokines 7 (e.g. IL-1β, IL-6 and TNF-α) 8 . Released cytokines are subsequently able to induce a variety of physiological changes like fever, widening of the blood vessels and attraction of other immune-cells, which sometimes lead to severe consequences including tissue destruction, multiple organ failure and death. 6 Therefore, the removal of pyrogenic contamination is of great importance especially in medical practice and in the pharmaceutical industry, where vials containing liquids to be injected must be totally free from pyrogenic contamination. However, elimination of pyrogens (depyrogenation) is a sensitive topic, because pyrogens are not easy to detect and difficult to remove.
Concerning pyrogen detection, two tests are currently in use -the rabbit pyrogen test 9 and the Limulus amebocyte lysate assay. 10 Pyrogen safety testing of materials and surfaces using these methods is, however, problematic because only the liquid extract of a solution used to wash the surface can be employed. It has been shown that LPS is only extractable to a certain extent, while residuals stick on the surface and thus cannot be detected by the pyrogen-testing procedures mentioned above. [11] [12] [13] [14] Furthermore, it has also been shown that the inflammatory capacity of some pyrogens can increase when they are bound on surfaces compared to the cytokine release evoked by pyrogens in the liquid state; 15 consequently, this can lead to the underestimation of possible risks when testing eluates.
Therefore, a new pyrogen testing method, recently validated in a collaborative European study, 16 has been used to evaluate directly the pyrogen contamination of surfaces by an indirect detection method. By adding isolated compounds of bacteria cell walls (e.g. LPS, LTA and peptidoglycan) to human whole-blood and following measurement of the released cytokines, it is possible to simulate the human fever reaction to immune-stimulating principles in vitro. Moreover, it is also possible to adapt the test principle to the use of cryopreserved blood which gives the great advantage of increased sensitivity, standardization and easy availability. 17 As mentioned above, the destruction of pyrogens also introduced new challenges. In principle, medical devices can be sterilized or decontaminated with a broad spectrum of techniques, including dry heat, autoclaving, gamma radiation, or ethylene oxide (EtO) treatment. However, these methods suffer several limitations. For example, ethylene oxide gas treatment is inefficient and costly; in addition, it is mutagenic and carcinogenic and, therefore, highly toxic to the working personnel and the environment. The gamma sterilization approach is difficult, expensive and can induce unfavorable changes of the bulk properties of, for example, polymeric materials. Radioactive sources require expensive waste disposal procedures as well as radiation safety precautions. Finally, any procedure involving high temperatures (e.g. dry heat or high-pressure autoclaving) is unsuitable for treatment of any heat-sensitive materials, like polymeric based parts of devices or instruments. Furthermore, none of these techniques completely removes pyrogens from a surface.
The newer and most promising sterilization or decontamination techniques are based on the use of non-equilibrium plasma discharges as reviewed elsewhere. [18] [19] [20] Such discharges are usually produced by subjecting a gas or gas mixtures to an electric field, either of constant or alternating amplitude. The charged particles, especially light electrons, are accelerated in the applied electric field and couple their energy into plasma via inelastic collisions with other particles. [21] [22] [23] These collisions lead to the production of ions, chemically active particles (e.g. O, H, OH) or excited particles having high internal energy. Such created particles can subsequently interact with the treated substrate, which can lead to physical cleaning of the surface or to an induction of chemical modifications at low temperature. Moreover, radiative de-excitation of excited particles can result in generation of intense UV radiation, which may also effectively alter the chemical composition of the treated substances.
Compared to conventional sterilization and decontamination methods, non-equilibrium plasma discharges offer fundamental advantages -they can be operated at low temperatures suitable for the treatment of heat-sensitive materials and since they are usually sustained in non-toxic gases like hydrogen, oxygen, nitrogen, argon or air, their operation is harmless both for the operator and the environment. For these reasons, plasma-based sterilization and decontamination techniques have attracted increased attention in recent years, as illustrated by the number of publications devoted to this topic. [24] [25] [26] [27] [28] [29] Concerning the applicability of non-equilibrium discharges for depyrogenation, it was recently reported by our group that low-pressure microwave discharges reduce, significantly, the bioactivity of LPS (from Escherichia coli O111:B4) within several minutes of plasma treatment. [30] [31] [32] It was demonstrated that the observed depyrogenation effect was not related to the possible side effects taking part during plasma processing of samples (e.g. low-pressure conditions, increased temperature or microwave radiation), but it was connected directly with the plasma-LPS interaction. 31 This distinguishes our process from the plasma sterilization system Sterrad 100 and 100s, 33 which relies on the action of hydrogen peroxide to sterilize the surfaces, without a depyrogenation effect. By comparing the depyrogenation results with the properties of employed discharges, determined by several plasma diagnostic methods (optical emission spectroscopy, Langmuir probe measurements and IR pyrometry), it was furthermore possible to identify the crucial depyrogenation agent. It was shown that variations of the UV intensity in the spectral range 200-300 nm or the density of charged particles produced by the discharge did not influence, significantly, the bioactivity decrease and that addition of hydrogen was the only influencing factor. 30 Although, these results were promising in terms of application of discharges for LPS elimination, up until now there was no experimental evidence that plasma discharges can also destroy other immune-stimulating substances. The objective of this report was to combine both the new pyrogen detection method as well as the plasma discharge based depyrogenation directly on a heat-sensitive surface in order to verify the possibility of detection and destruction of selected immune-stimulating substances. Here, we report the results reached employing LPS derived from different bacterial strains, LTA differing in the level of their purity and zymosan derived from the yeast cell wall (Saccharomyces cerevisiae). 34 Moreover, the effect of addition of muramyl dipeptide (MDP) to LPS was investigated in order to mimic bacterial cell-wall residues presented on the surfaces.
MATERIALS AND METHODS

Materials
LPSs from E. coli O111:B4, E. coli K-235, Salmonella abortus equi (Sigma-Aldrich S.r.l., Milan, Italy) and LTA from Staph. aureus prepared according to Morath et al. 35 (a gift from the Chair of Biochemical Pharmacology, University of Konstanz) were used to produce a controlled surface contamination. In addition, muramyl dipeptide (MDP), LTA from Staph. aureus and Bacillus subtilis and zymosan (InvivoGen, San Diego, CA, USA) were employed. Incubations were performed in 24-well-plates (Becton Dickinson S.p.A., Buccinasco, MI, Italy). All accessories and solvents were of pyrogen-free quality.
Whole blood incubation
Blood was drawn from healthy volunteers into tubes containing 15 IU/ml Li-Heparin (Sarstedt, Nürnbrecht, Germany). Dried and plasma-treated samples were incubated with 100 µl heparinized fresh blood diluted in isotonic saline to a total volume of 1000 µl for 24 h at 37°C and 5% CO 2 . Cell-free supernatants were obtained from blood by centrifugation at 13,000 rpm for 2 min and were assayed immediately or stored at -80°C until analysis. ELISA measured cytokine release of IL-1β was detected with commercially available antibody pairs (R&D systems, Space Import-Export srl, Milano, Italy). Detection of the biotinylated antibody was quantified by streptavidin-peroxidase (Biosource, Prodotti Gianni SpA, Milano, Italy) and its substrate TMB (3,3′,5,5′tetramethylbenzidine; Sigma, Italy). Recombinant cytokines were used as standards (National Institute of Biological Standard and Control, South Mimms, UK).
Sample preparation
To create a controlled surface for contamination by pyrogens, 24-well plates were incubated with 100 µl of LPS, LTA or zymosan diluted to a final amount of 0.01-10 ng/ml for LPS, 1-10 µg/ml for LTA and 0.1-10 µg/ml for zymosan. In the case of combined stimuli (e.g. LPS [1 ng/ml] and MDP [0.1 and 1 µg/ml]), both stimuli were added together at the final concentration and brought onto the surface in 100 µl aliquots. The plates were dried overnight in a common flow-hood, exposed to the plasma discharge and processed with the wholeblood incubation the next day in order to estimate remaining biological activity of the deposit.
Plasma reactor
All depyrogenation experiments were carried out using the plasma reactor (developed and manufactured in-Plasma-based removal of pyrogens from surfaces 91 Fig. 1 . Schematic picture of the plasma generator. MW, microwave supply; C, circulator; 3S, three-stub impedance matching system; R-C, rectangular-circular waveguide transition; SiW, silica window; F, mass flow controller; AVS, monochromator; Ar, argon supply; H 2 , hydrogen supply. house) identical to the one used in our previous studies [30] [31] [32] and schematically depicted in Figure 1 . It consists of a stainless-steel, cylindrical, vacuum chamber (200 mm in diameter and 380 mm in length) equipped with several diagnostic windows and one port for sample introduction. The processing chamber is connected to the gas inlet system, which is composed of MKS mass flow controllers (F) attached to the gas lines (H 2 and O 2 ); it is evacuated by a primary pump and a roots blower allowing a base vacuum of 0.3 Pa.
The plasma is sustained by microwaves with excitation frequency of 2.45 GHz. The microwave circuit includes the microwave supply (MW), a circulator (C) protecting the power supply from the reflected power, a three-stub impedance matching system (3S), and a rectangular-circular wave-guide transition (R-C). Microwaves are introduced into the plasma chamber through a silica window (SiW) placed at the extremity of a circular 100-mm wave-guide.
In order to monitor the stability of the discharge during plasma processing of the samples, measurements of the optical emission spectra were performed during plasma treatment by means of an Avantes AVS-PC2000 monochromator (AVS) equipped with a 2048-element linear CCD in the spectral range 200-900 nm.
Plasma treatment
The applied parameters were the same for all the experiments described in this article. The plasma was sustained at a pressure of 13.3 Pa and at a total gas flow of 100 sccm using an applied microwave power of 1000 W. The gas mixture was made of O 2 /H 2 (50/50) -the mixture previously identified as one of the most potent in terms of the elimination of biological contamination (see Kylián et al. 30 for details).
Statistics
Statistical analysis was performed with GraphPad InStat v.4.0 (GraphPad Software; San Diego, CA, USA). Significance was tested by two-way ANOVA with Bonferroni post-test on the raw data. Some data are shown in percentages of IL-1β release compared to the untreated control, others as IL-1β release in a linear or a logarithmic scale.
RESULTS
Homogeneity, reproducibility and time stability of the plasma treatment
In order to assess the homogeneity of our newly established system, four 24-well-plates were coated with 1 ng/ml of LPS from E. coli O111:B4, dried overnight, and then treated for 60 s. As can be seen in Figure 2 , measured LPS signals differ only slightly from well to well (CV coefficient of variation is 10%), i.e. the experimental set-up enables us to plasma-treat equally the whole area of the 24-well plates intended for the depyrogenation tests. In order to estimate the reproducibility of both sample preparation and plasma treatment, six 24-well plates were coated with different LPS (E. coli O111:B4) concentrations. Three 24-well plates were used as untreated controls and three were plasma-treated under the same experimental conditions. As shown in Figure 3 , for both groups of samples, coefficients of variation were less than 30%.
Another important parameter that can influence the temporal evolution of treatment efficiency is the time variation of the discharge properties. In order to verify the stability of the used experimental set-up, the dis- charge properties were monitored during its operation by optical emission spectroscopy. Almost no temporal variations of the intensities of the detected spectral lines were observed (Fig. 4) , which demonstrates that the discharge is stable in the time-scale typically used for the depyrogenation experiments.
LPS de-activation
An example of the dependencies of LPS bioactivity on the plasma treatment time and on the initially deposited LPS amount is given in Figure 5 for the LPS derived from E. coli K-235. It can be clearly seen that plasma treatment leads to a significant reduction of pyrogenic activity of the contaminated surfaces as compared to the untreated samples. Moreover, the depyrogenation efficiency is markedly faster for the lower concentrations of deposited LPS and, in all cases, non-linear time evolution of pyrogenic decrease was observed. The most pronounced reduction of LPS bioactivity occurred during the first 10-60 s of the plasma treatment followed by a progressive slowing down of the bioactivity decrease. Qualitatively, the same behavior was observed for LPS derived from different bacterial strains. Nevertheless, the depyrogenation efficiency for LPS derived from dif- ferent bacterial strains revealed significant variations between species. The fastest decrease was observed for the LPS derived from E. coli O111:B4, for which the detection limit was reached at low LPS concentration after 30 s, followed by S. abortus equi LPS and E. coli K-235. This observation is supported when the normalized measured values of IL-1β after 10 s and 300 s of plasma treatment are compared (Fig. 6 ).
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Lipoteichoic acid
Lipoteichoic acid from two different bacteria (B. subtilis [BsLTA] and Staph. aureus [SaLTA]) was used and a time-dependent removal of the biological activity could be observed (Fig. 7) . Moreover, it was found that the removal rate did not differ markedly for BsLTA and SaLTA. For both, a significant decrease (P < 0.001) was found after 10 s of plasma treatment; after 5 min, a nearly complete elimination of the resulting bioactivity signal was observed.
Concerning the effect of the purity of LTA, it was found that LTA prepared commercially (SaLTA and BsLTA) showed a higher cytokine-release in the untreated control than highly purified pSaLTA. Furthermore, it can be seen, that the removal rate is considerably faster in the case of highly purified LTA compared to the commercially prepared samples. In this case, a 30-s treatment was sufficient to reach the detection limit of the test instead of 5 min necessary in the case of SaLTA and BsLTA. This result demonstrates the effect of impurities in the LTA preparation that can interfere with the results of the treatment.
Zymosan
Compared to LPS, a 1000-10,000-fold higher concentration of zymosan had to be coated on the surface to induce the same cytokine release (Fig. 8 ). After 30 s of plasma treatment, a nearly 50% removal of the bioactivity for the 10 µ g/ml concentration could be observed. The 1 µg/ml concentration showed a faster decrease, comparable to the slope of removal we detected in the case of LPS.
LPS and MDP
In order to mimic the bacterial cell wall, additional tests were made using a coating mixture composed of LPS 94 Hasiwa, Kylián, Hartung, Rossi Fig. 7 . LTA from B. subtilis (BsLTA), Staph. aureus (SaLTA) and ultrapurified SaLTA (pSaLTA) in a time course (human whole blood incubation with following IL-1β ELISA). Applied power, 1000 W; pressure, 13.3 Pa; gas flow, 100 sccm; gas mixture, O 2 /H 2 (50/50)). *P < 0.05; ***P < 0.001 versus the according control, two-way ANOVA with Bonferroni post-test. Fig. 8 . Zymosan and LPS plasma treated for 10 and 30s (human whole blood incubation with following IL-1β ELISA). Applied power, 1000 W; pressure, 13.3 Pa; gas flow, 100 sccm; gas mixture, O 2 /H 2 (50/50)). Fig. 9 . The synergistic effect of LPS and MDP together in two concentrations with four different plasma treatment times (human whole blood incubation and following IL-1β ELISA). Applied power, 1000 W; pressure, 13.3 Pa; gas flow, 100 sccm; gas mixture, O 2 /H 2 (50/50). and MDP onto the surface (Fig. 9 ). The synergistic effect 36 was observed with both added MDP concentrations (1 and 10 µg/ml) but a removal rate similar to LPS alone at higher concentrations was observed.
DISCUSSION
After routine sterilization, surgical instruments, implants, or medical devices are considered as clean. Bacterial contamination is normally destroyed, as it is controlled by microbiological tests routinely performed in hospitals and testing facilities. However, there is strong evidence that remaining components on the surface can be responsible for transmission of diseases 37 or invoke an immune response, 38 which can lead to severe consequences.
By modeling the natural situation via coating immunestimulating components like LPS, LTA, zymosan and their combinations on polystyrene surfaces, we were able to show first that these compounds can be detected directly on the surface 14 by an indirect test, which was not possible until now by any of the established pyrogen tests. Second, by applying low-pressure microwave plasma discharge, we were able to decrease the biological activity of most of the substances at high rates, and temperatures below 60°C, i.e. at temperatures suitable for treatment of many polymer-based materials. This has to be compared to the depyrogenation procedure normally used in the pharmaceutical industry where glassware treatment of 30 min at 250°C has to be applied for pyrogen removal.
To establish and evaluate the quality of our method, several tests related to reproducibility, homogeneity, and time stability of the plasma treatment were carried out. Concerning the homogeneity of the plasma treatment, measurements with four different plates coated with one concentration of pyrogen showed a coefficient of variance over the plate of about 10%. Therefore, the plasma can be considered as homogeneous over the whole plate in a reproducible and reliable way. The reproducibility of three independent experiments performed under the same conditions employing a concentration range from 100 pg/ml to 10 ng/ml showed a coefficient of variance of less than 30% which is common for biological systems with many individual steps and reactions taking place that depend on buffer quality, temperature or humidity.
Concerning the depyrogenation experiments, we found a very fast removal rate of the biological activity for LPS, which is known to be sticky on surfaces and extremely difficult to remove. According to the obtained results, up to 2-log reduction of the pyrogenicity expressed in terms of IL-1β release capacities can be observed within few minutes of plasma treatment, depending on the initial concentration of deposited LPS.
To compare this with conventional methods, a reduction in the same range was reached at 170°C after 120 min 39 or at 200°C after 20 min. 40 The reduction of the biological signal is a non-linear function of time. Initially, a fast decrease has been observed followed by an apparently slower removal rate. This effect can be possibly ascribed to the non-homogeneous coated layer of LPS and its characteristic to form supramolecular aggregates, 41 or to the fact that the components of the contamination which can produce volatile breakdown products are removed first, with the remaining contamination enriching progressively in non-volatile elements like P, Ca, Na, etc.
The fact that LPSs from E. coli K-235 and S. abortus equi have a slower removal kinetic compared to the LPS from E. coli O111:B4 can not be explained yet. It is probable that the size, the structure or the molecular packaging are influencing the removal rate.
Lipoteichoic acid, one of the immune-stimulating molecules of Gram-positive bacteria, has gained more importance latterly. LTA is not as potent as LPS in evoking immune response, and normally higher concentrations are necessary to reach a comparable cytokine release. In our study, LTA from two different organisms was employed (B. subtilis and Staph. aureus); nevertheless, their biological signal and also the removal rate was the same for both. However, highly purified LTA showed a lower starting signal and was easier to remove. This gives evidence to the conclusion that purer substances show a higher removal efficiency compared to substances which include impurities, like proteins, other immune-stimulating components or salts, which are possibly able to protect the reactive parts from the plasma interaction. In the case of LTA, an LPS-contamination could also play a role. The manufacturer gives Limulus amebocyte lysate assay values of 125 EU/ml for SaLTA, 12.5 EU/ml for BsLTA, whereas the highly purified pSaLTA is guaranteed to have endotoxin contents lower than 1 EU/ml. On the other hand, comparing the contamination of SaLTA, which is 10 times higher than in BsLTA, with the resulting starting signal in the untreated control showed no difference. Furthermore, for LPS we also observed a very fast removal rate, so there should be no difference according to the removal efficiency.
Zymosan, an insoluble yeast preparation, represents a fungal contamination which is known to induce immune responses and cytokine release; therefore, it has been used in many physiological and immunological studies. [42] [43] [44] It seems that the different donors are reacting inhomogeneously towards that stimulus, as is indicated by relatively high standard variations. Nevertheless, it was demonstrated that the biological activity of zymosan could also be eliminated by the means of plasma discharge.
We tried also to mimic bacterial cell-wall residues by combining two components -LPS and muramyl dipeptide (MDP). MDP is the smallest break-down product of peptidoglycan, which itself has no immune stimulatory effect, but it is known to produce a synergetic effect with LPS or LTA (it enhances their activity as measured by TNF release by about 3-log orders 36, 45 ). Mixing these two substances, we expected to observe an effect, i.e. the decrease of plasma treatment efficiency with an increasing amount of MDP. This was not the case. The removal rate was as fast as for LPS alone; the increased cytokine signal for the combined situation had a removal rate similar to LPS in higher concentrations.
The possible use of the proposed method could be in the medical industry and in testing facilities. The plasma-based removal of pyrogenic surface contaminations for heat-sensitive devices could be used after several washing steps for the final decontamination, while human whole-blood incubation could give confirmation that the surface is able to be brought into contact with the human immune system without stimulating the immune cells to release mediator substances. Before introducing our model to routine cleaning or testing protocols, a formal validation should be performed, which should confirm the reliability and the reproducibility of the test. The limit of detection might be overcome by using Immuno-PCR 46 or by using more sensitive cells. The application is limited to materials which are not toxic to blood cells, as seen with some metal types (data not shown) or materials which would interfere with the release of messenger substances by the blood cells. Therefore, proper controls (such as adding an LPS spike) should be always included. Our assay is supposed to model the human fever reaction by the blood cells coming in contact with immune-stimulating components and an induced concentration-dependent mediator release. If this reaction is enhanced by an immune-stimulus sticking on the surface, by the surface itself or other influencing factors, we still model the situation like the human immune-system would react in case of coming into contact with the investigated material.
The proposed method seems promising to enhance consumer safety by cleaning medical devices in a more efficient way and by detecting immune-stimulating components sticking on the surface by using human wholeblood assay, which gives an indirect measure of the surface-bound contaminations.
CONCLUSIONS
We found that the human whole-blood incubation test is a sensitive method to detect residues of immune-stimulating components directly on the surface by an indirect test, without the problem of preparing eluates and related losses on the surface. Furthermore, we found that the low-pressure microwave discharge plasma is an appropriate method to eliminate various immunestimulating components relatively quickly, under lowtemperature conditions preventing treated substrates from the heat-induced modifications and without the necessity of using toxic compounds. This was demonstrated first for LPS, the most potent immune-stimulatory component that can be removed in a reliable way and with fast kinetics, even if the signal is synergistically increased by another substance. Gram-positive stimuli, which are gaining more and more importance, could be removed as well with a very fast removal rate. Also zymosan, a monocyte and macrophage stimulus, was removable to a major extent. Nevertheless, how plasma interacts with surface-bound molecules is still unclear. Further studies on the interaction of immune-stimulating components with surfaces and their plasma-based removal are on-going.
